Showing results (141-150 of 280) with videos related to

Sort By:
Pageof 28
Clinical Genitourinary Cancer|June 4, 2023
Relationship Between Pretreatment Body Composition and Clinical Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving First-Line Ipilimumab Plus NivolumabHannah D McManus, Dylan Zhang, Fides R Schwartz, et al.
The Journal of Urology|September 18, 2007
Sunitinib efficacy against advanced renal cell carcinomaRobert J Motzer, M Dror Michaelson, Jonathan Rosenberg, et al.
Molecular Cancer Research : MCR|June 14, 2011
Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markersAndrew J Armstrong, Matthew S Marengo, Sebastian Oltean, et al.
Kidney Cancer (Clifton, Va.)|October 11, 2021
Real-World Utilization of Oral Anticancer Agents and Related Costs in Older Adults with Metastatic Renal Cell Carcinoma in the United StatesLauren E Wilson, Lisa Spees, Jessica Pritchard, et al.
Current Medical Research and Opinion|August 9, 2014
Comparative effectiveness of second-line targeted therapies for metastatic renal cell carcinoma: synthesis of findings from two multi-practice chart reviews in the United StatesJames E Signorovitch, Nicholas J Vogelzang, Sumanta K Pal, et al.
Radiology|August 9, 2013
Bone marrow biopsy: RNA isolation with expression profiling in men with metastatic castration-resistant prostate cancer--factors affecting diagnostic successCharles E Spritzer, P Diana Afonso, Emily N Vinson, et al.
Urologic Oncology|July 23, 2019
Clinical utility of FoundationOne tissue molecular profiling in men with metastatic prostate cancerJason Zhu, Matthew Tucker, Daniele Marin, et al.
Expert Opinion on Pharmacotherapy|March 14, 2015
Prognostic factors for survival following initiation of second-line treatment with everolimus for metastatic renal cell carcinoma: evidence from a nationwide sample of clinical practice in the United StatesMichael K Wong, Eric Jonasch, Sumanta K Pal, et al.
European Urology Oncology|December 24, 2023
Testosterone Recovery for Relugolix Versus Leuprolide in Men with Advanced Prostate Cancer: Results from the Phase 3 HERO StudyRonald Tutrone, Fred Saad, Daniel J George, et al.
Cancer Investigation|March 21, 2002
A phase II trial of interferon-alpha and toremifene in advanced renal cell cancer patientsWilliam K Oh, Judith Manola, Daniel J George, et al.
Pageof 28